The board of directors of China Resources Pharmaceutical Group Limited announces that, with effect from 13 February 2023, Mdm. Guo Wei ("Mdm. Guo") has been appointed as a non-executive Director. Mdm. Guo Wei, aged 46, currently serves as an external director of the business unit at China Resources Corporate Service (Shenzhen) Limited was a non-executive Director from May 2019 to September 2021, and was a deputy financial director of the Finance
Department of China Resources (Holdings) Company Limited from April 2017 to November 2022. Mdm. Guo was a director of China Resources Double-Crane Pharmaceutical Company Limited (, the shares of which are listed on the Shanghai Stock Exchange and a non-wholly owned subsidiary of the Company) from December 2015 to September 2021 and a director of China Resources Sanjiu Medical & Pharmaceutical Company Limited (, the shares of which are listed on the Shenzhen Stock Exchange (stock code: 000999) and a non-wholly owned subsidiary of the Company) from April 2018 to September 2021. Mdm. Guo
holds a bachelor's degree in economics from University of International Business and Economics, China and a master's degree in law from Peking University, China.
There is no service contract entered into between Mdm. Guo and the Company for her position as a non-executive Director. Mdm. Guo shall hold office until the next general meeting of the Company after her appointment and shall then be eligible for re-election at such meeting. Thereafter, Mdm. Guo shall be subject to retirement by rotation at least once every three years at the annual general meeting pursuant to the articles of association of the Company. Mdm. Guo will not receive any director's emolument from the Company.